Glaxo Wellcome Malarone
Executive Summary
Combination malaria drug deemed "approvable" by FDA June 30. The drug combines atovaquone (Mepron) and proguanil
Combination malaria drug deemed "approvable" by FDA June 30. The drug combines atovaquone (Mepron) and proguanil. |